The European Commission is not involved in the assessment of individual medical devices. However, the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs closely follows trends in science and technology with a view to adapting the regulatory framework as necessary.
Once a precise scientific matter is raised, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) is consulted.
Previously, SCHEER and its predecessor SCENIHR have been consulted on the following issues:
The Working Group on New and Emerging Technologies in Medical Devices focuses on new technologies. These include devices used in relation to artificial organs or other advanced implants, minimal invasive surgery, telemedicine, radio-frequency identification, in vitro diagnostic devices or nanomaterials (70 kB).